News
BryoLogyx Announces Completion of World’s First GMP Synthesis of Bryostatin-1
BryoLogyx, Inc., announced that it has completed the synthesis of bryostatin-1 molecule, pursuant to FDA’s Good Manufacturing Practice (GMP) regulations. Bryostatin-1 is the company’s lead...
Clinical Trials
Johnson & Johnson Temporarily Pauses All Dosing in Our Janssen COVID-19 Vaccine Candidate Clinical Trials
At Johnson & Johnson, there is no greater priority than the safety and well being of the people we serve every day around the world....
News
New Zealand signs deal with Pfizer, BioNTech for Covid-19 vaccine
The New Zealand government signed a deal on Monday to buy 1.5 million COVID-19 vaccines from Pfizer Inc and Germany’s BioNTech, with delivery potentially as...
News
Pistoia Alliance launches seed fund to drive biopharma and healthcare innovation
The Pistoia Alliance, a global, not-for-profit alliance that works to lower barriers to innovation in life science and healthcare R&D, launched its new Innovation Seed...
News
High Purity New England Introduces Defined Tubing Routing for Single-Use Facilities
High Purity New England (HPNE), a leading supplier of biopharma equipment and process systems for the Biopharma industry announces its new line of Defined Tubing...
News
China’s Experimental COVID-19 Vaccine Appears Safe In Early Trials Study
COVID-19 Vaccine: In a Phase 1 trial of 191 healthy participants aged between 18 and 59, vaccination with the group's experimental shot showed no severe...
News
Second UK Covid-19 vaccine manufacturing site gets MHRA approval
The second of two GMP manufacturing sites for the UK’s specialist vaccines manufacturing equipment has been approved by the Medicines & Healthcare products Regulatory Agency...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.